Opioid maker Insys Therapeutics has agreed to a $225 million global resolution to settle the government’s separate criminal and civil investigations concerning deceptive marketing and distribution of its opioid drug, Subsys.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...